Norwalk Leslie V
Transaction: 07/29/2026
SELL
Change
-842
Price
$139.43
Filing
07/30/2026
Type
SELL
Neurocrine Biosciences, Inc.
NBIX • Biotechnology
$0.00
— 0.00 (0.00%)
EarningsLatest report: Jun 30, 2026
HIGHLY FAVORABLE PROFILEExcellentConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Strong business quality with supportive growth and cash-flow evidence. Valuation still matters, but the historical ratio profile is favorable.
Market Cap
$18.65B
Growth
11.4%
Cash Flow
5/5
Trend
Stable
Evidence
Stable or improving margins · 16.7%Positive revenue growth · 24.5%Positive free cash flow · 7.52Consistent free cash flow · 5/5Manageable debt level · 0.13
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$0.00
Change0.00%
Market Cap$18.65B
52W Range122.14 - 186.12
Beta0.39
Gross Margin98.18%
Oper. Margin21.64%
Profit Margin16.73%
Debt/Eq0.13
Current Ratio3.39
Quick Ratio3.30
Revenue 5Y11.36%
Price$0.00
Change0.00%
Market Cap$18.65B
52W Range122.14 - 186.12
Beta0.39
Gross Margin98.18%
Oper. Margin21.64%
Profit Margin16.73%
Debt/Eq0.13
Current Ratio3.39
Quick Ratio3.30
Revenue 5Y11.36%
FCF 5Y11.87%
Target$197.25
Target Median$197.50
Target Range160.00 - 230.00
Volume2.17M
Avg Volume1.21M
EPS Surprise0.72
Investment DNA
How strong this company looks for long-term investors
84
out of 100
Business Quality
Margins, moat, returns
86/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
57/100
Why this score▼
Stable or improving margins · 16.7%Positive revenue growth · 24.5%Positive free cash flow · 7.52Consistent free cash flow · 5/5Manageable debt level · 0.13Healthy liquidity · 3.39
Analyst view
Analyst sentiment and price target
Analyst sentiment
No vote count available
Bullish
0
Hold
0
Bearish
0
Price Target
2026-07-31
Low
$160.00
Mean
$197.25
Median
$197.50
High
$230.00
Insider Transactions
Recent executive and insider activity
Norwalk Leslie V
Transaction: 07/29/2026
BUY
Change
+842
Price
$139.43
Filing
07/30/2026
Type
BUY
Norwalk Leslie V
Transaction: 07/28/2026
SELL
Change
-1,250
Price
$182.01
Filing
07/30/2026
Type
SELL
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Norwalk Leslie V | SELL | -842 | $139.43 | 07/29/2026 | 07/30/2026 |
| Norwalk Leslie V | BUY | +842 | $139.43 | 07/29/2026 | 07/30/2026 |
| Norwalk Leslie V | SELL | -1,250 | $182.01 | 07/28/2026 | 07/30/2026 |
| Delaet Ingrid | SELL | -4,367 | $106.02 | 07/10/2026 | 07/13/2026 |
| Delaet Ingrid | SELL | -4,367 | $181.02 | 07/10/2026 | 07/13/2026 |
| Lippoldt Darin | SELL | -10,000 | $81.49 | 07/09/2026 | 07/13/2026 |
| Lippoldt Darin | SELL | -10,000 | $179.60 | 07/09/2026 | 07/13/2026 |
| Delaet Ingrid | SELL | -8,433 | $103.52 | 07/09/2026 | 07/09/2026 |
| Delaet Ingrid | SELL | -8,433 | $178.72 | 07/09/2026 | 07/09/2026 |
| Delaet Ingrid | SELL | -2,737 | $103.52 | 07/08/2026 | 07/09/2026 |
| Delaet Ingrid | SELL | -2,737 | $178.54 | 07/08/2026 | 07/09/2026 |
| Delaet Ingrid | SELL | -3,401 | $103.52 | 07/07/2026 | 07/09/2026 |
| Delaet Ingrid | SELL | -3,401 | $178.57 | 07/07/2026 | 07/09/2026 |
| Lippoldt Darin | SELL | -1,690 | $81.49 | 06/29/2026 | 06/30/2026 |
| Lippoldt Darin | SELL | -1,690 | $170.81 | 06/29/2026 | 06/30/2026 |
| Lippoldt Darin | SELL | -200 | $81.49 | 06/26/2026 | 06/30/2026 |
| Lippoldt Darin | SELL | -200 | $169.56 | 06/26/2026 | 06/30/2026 |
| Onyia Jude | SELL | -2,441 | Not reported | 06/05/2026 | 06/09/2026 |
| SHERWIN STEPHEN A | SELL | -10,000 | $79.79 | 06/05/2026 | 06/09/2026 |
| SHERWIN STEPHEN A | SELL | -1,843 | $167.31 | 06/05/2026 | 06/09/2026 |